Insulin resistance improves in hyperandrogenic women treated with Lupron *†‡

Autor: Elkind-Hirsch, Karen E., Valdes, Cecilia T., Russell Malinak, L.
Zdroj: Fertility and Sterility; October 1993, Vol. 60 Issue: 4 p634-641, 8p
Abstrakt: To examine if changes in insulin sensitivity and glucose effectiveness in women with polycystic ovarian disease (PCOD) occurred after ovarian androgen suppression with a GnRH agonist, leuprolide acetate (LA, Lupron; TAP Pharmaceuticals, Deerfield, IL) using the minimal model method.
Databáze: Supplemental Index